Safety Efforts in Pediatric Drug Development
por
Conor D. Byrne
Aún sin calificaciones
Children’s
Formato
Tapa dura
Páginas
133
Idioma
Esloveno
Publicado
Jun 1, 2009
Editorial
Nova Science Pub Inc
Edición
1
ISBN-10
1607415658
ISBN-13
9781607415657
Descripción
This comprehensive exploration delves into the intricacies of pediatric drug development, focusing on the vital safety measures that underpin the process. It highlights the unique challenges faced when researching and testing medications intended for children, whose physiological and psychological differences from adults necessitate a specialized approach. By examining case studies and regulatory frameworks, it reveals how the pharmaceutical industry strives to ensure that drugs are both effective and safe for younger populations.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
The narrative also emphasizes the importance of collaboration among researchers, healthcare professionals, and regulatory bodies. It provides insight into the evolving role of regulations that govern safety testing and how these impact the availability of pediatric medications. This collaborative effort is crucial in advancing knowledge and fostering innovation in drug development for children.
Readers will appreciate the blend of scientific rigor with real-world implications, making this an essential resource for anyone involved in pediatric healthcare, drug development, or regulatory science. The discussions set the stage for informed decision-making in an area where patient safety is paramount.
Reseñas
No hay reseñas aún
Sé el primero en reseñar este libro y compartir tus pensamientos
Añadir Primera ReseñaRegistro de lectura
No se encontraron registros de lectura
Empieza a rastrear tu progreso de lectura para ver los registros aquí
Agrega tu primer registro de lecturaNotas
Registro de transacciones
No se encontraron registros de transacciones
Empieza a rastrear tus transacciones de libros para ver los registros aquí
Agrega tu primer registro de transacciones